Jacobson IM - Search Results

1

Bacterial Endocarditis Following Deep Enteroscopy: Is Prophylaxis Warranted?

Ferm S, Siu MK, Chhetry M, Jacobson IM, Tay S, Rubin M. Ferm S, et al. Among authors: jacobson im. ACG Case Rep J. 2019 Oct 31;6(10):e00206. doi: 10.14309/crj.0000000000000206. eCollection 2019 Oct. ACG Case Rep J. 2019. PMID: 31832451 Free PMC article.

2

Editorial: bodybuilders beware.

Feldman DM, Jacobson IM. Feldman DM, et al. Among authors: jacobson im. Aliment Pharmacol Ther. 2019 Jun;49(12):1530. doi: 10.1111/apt.15270. Aliment Pharmacol Ther. 2019. PMID: 31134650 No abstract available.

3

The extinction of chronic viral hepatitis?

Kumar S, Jacobson IM. Kumar S, et al. Among authors: jacobson im. Clin Liver Dis (Hoboken). 2015 Sep 29;6(3):75-77. doi: 10.1002/cld.502. eCollection 2015 Sep. Clin Liver Dis (Hoboken). 2015. PMID: 31040993 Free PMC article. Review. No abstract available.

4

A pangenotypic, single tablet regimen of sofosbuvir/velpatasvir for the treatment of chronic hepatitis C infection.

Weisberg IS, Jacobson IM. Weisberg IS, et al. Among authors: jacobson im. Expert Opin Pharmacother. 2017 Apr;18(5):535-543. doi: 10.1080/14656566.2017.1282459. Epub 2017 Mar 24. Expert Opin Pharmacother. 2017. PMID: 28092171 Review.

5

Sofosbuvir, velpatasvir and voxilaprevir combination for the treatment of hepatitis C.

Voaklander R, Jacobson IM. Voaklander R, et al. Among authors: jacobson im. Expert Rev Gastroenterol Hepatol. 2017 Sep;11(9):789-795. doi: 10.1080/17474124.2017.1351295. Epub 2017 Jul 31. Expert Rev Gastroenterol Hepatol. 2017. PMID: 28673106 Review.

6

The HCV Treatment Revolution Continues: Resistance Considerations, Pangenotypic Efficacy, and Advances in Challenging Populations.

Jacobson IM. Jacobson IM. Gastroenterol Hepatol (N Y). 2016 Oct;12(10 Suppl 4):1-11. Gastroenterol Hepatol (N Y). 2016. PMID: 28070174 Free PMC article.

7

Hepatitis E Virus Infection in the United States: Current Understanding of the Prevalence and Significance in the Liver Transplant Patient Population and Proposed Diagnostic and Treatment Strategies.

Whitsett M, Feldman DM, Jacobson I. Whitsett M, et al. Liver Transpl. 2020 May;26(5):709-717. doi: 10.1002/lt.25732. Liver Transpl. 2020. PMID: 32061053 Review.

8

Hepatitis C-A clinical review.

Wang LS, D'Souza LS, Jacobson IM. Wang LS, et al. Among authors: jacobson im. J Med Virol. 2016 Nov;88(11):1844-55. doi: 10.1002/jmv.24554. Epub 2016 Apr 29. J Med Virol. 2016. PMID: 27097298 Review.

9

Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donors.

Reyentovich A, Gidea CG, Smith D, Lonze B, Kon Z, Fargnoli A, Pavone J, Rao S, Saraon T, Lewis T, Qian Y, Jacobson I, Moazami N. Reyentovich A, et al. Clin Transplant. 2020 Sep;34(9):e13989. doi: 10.1111/ctr.13989. Epub 2020 Aug 10. Clin Transplant. 2020. PMID: 32441413

10

Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.

Faruqui S, Okoli FC, Olsen SK, Feldman DM, Kalia HS, Park JS, Stanca CM, Figueroa Diaz V, Yuan S, Dagher NN, Sarkar SA, Theise ND, Kim S, Shanbhogue K, Jacobson IM. Faruqui S, et al. Among authors: jacobson im. Am J Gastroenterol. 2021 Jul 1;116(7):1414-1425. doi: 10.14309/ajg.0000000000001264. Am J Gastroenterol. 2021. PMID: 33993134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

218 results

Search Page